Thromb Haemost 1985; 54(03): 645-649
DOI: 10.1055/s-0038-1660089
Original Article
Schattauer GmbH Stuttgart

Platelet Membrane Potential: Simultaneous Measurement of diSC3(5) Fluorescence and Optical Density

Eva Pipili
The Department of Pharmacology, Medical School, University of Patras, Greece
› Author Affiliations
Further Information

Publication History

Received 19 April 1985

Accepted 30 July 1985

Publication Date:
19 July 2018 (online)

Summary

The role of membrane potential in the activation of human platelets by thrombin, ADP and PAF was assessed, using the fluorescent probe diSC3(5). Thrombin, ADP and PAF transiently depolarised the platelet membrane by 6-8 mV from its resting level (—70 mV). This depolarisation had a similar time course to that of shape change. The ionophores valinomycin and gramicidin hyperpolarised and depolarised the platelets respectively but did not activate them. In contrast, exposure of platelets to high K+ media both depolarised and caused them to change shape. Removal of Na+ from the suspension media abolished the depolarisation induced by thrombin, ADP and PAF but the platelets under these conditions were still capable of changing shape and aggregating. This result indicates that the observed depolarisation depends on Na+ fluxes. Amiloride or tetrodotoxin did not mimic the effect of Na+ removal suggesting that any Na+ movement involved does not go through the classic “Na+ channel”. Thrombin, ADP and PAF still depolarised the platelet membrane in the absence of added Ca+ +. Under these conditions, however, the membrane did not repolarise. It is evident that all three agents, thrombin, ADP and PAF, change the membrane potential of human washed platelets through a similar mechanism and this change seems to be a consequence of stimulus-receptor interaction (and platelet activation?). A causal relationship however between these events cannot be clearly shown.

 
  • References

  • 1 MacIntyre DE, Rink TJ. The role of platelet membrane potential in the initiation of platelet aggregation. Thromb Haemostas 1982; 47: 22-26
  • 2 Pipili E. Human platelet membrane potential assessed with a fluorescent probe. Br J Pharmacol 1982; 76: 202
  • 3 Friedhoff LT, Sonenberg M. The membrane potential of human platelets. Blood 1983; 16: 180-185
  • 4 Horne WC, Simons ER. Probes of transmembrane potential in platelets. Changes in cyanine dye fluorescence in response to aggregation stimuli. Blood 1978; 51: 741-749
  • 5 Horne WC, Norman NE, Schwartz DB, Simons ER. Changes in cytoplasmic pH and in membrane potential in thrombin stimulated human platelets. Eur J Biochem 1981; 120: 295-302
  • 6 Rink TJ. Measurement of membrane potential with chemical probes. In: Techniques in the Life Science, B4/11, Lipid and Membrane Biochemistry 1982; B423: 1-29
  • 7 Hallam TJ, Sanchez A, Rink TJ. Stimulus response coupling in human platelets. Changes evoked by platelet activating factor in cytoplasmic free calcium monitored with the fluorescent calcium indicator quin 21. Biochem J 1984; 218 (03) 819-827
  • 8 Born C VR. Aggregation of blood platelets and its reversal. Nature 1982; 194: 927-929
  • 9 Hladky SB, Rink TJ. Potential difference and the distribution of ions across the human red cell membrane: a study of the mechanism by which the fluorescent cation diSC3(5) reports membrane potential. J Physiol 1976; 263: 287-319
  • 10 Rink TJ, Montecucco C, Hesketh TR, Tsien RY. Lymphocyte membrane potential assessed with fluorescent probes. Biochim Bio-phys Acta 1980; 595: 15-30
  • 11 Haydon DA, Hladky SB. Ion transport across thin lipid membranes: a critical discussion of mechanisms in selected systems. Q Rev Biophys 1972; 5: 187-282
  • 12 Urban BW, Hladky SB, Haydon DA. The kinetics of ion movements in the gramicidin channel. Fed Proc 1978; 37: 2628-2632
  • 13 Peterson OH, Maruyama Y. Calcium activated potassium channels and their role in secretion. Nature 1984; 307: 693-696
  • 14 Greenberg-Sepersky SM, Simons ER. Cation gradient dependence of the steps in thrombin stimulation of human platelets. J Biol Chem 1984; 259 (03) 1502-1508
  • 15 MacIntyre DE, Shaw AM. Selective inhibition of PAF-induced human platelet aggregation by verapamil and methoxyverapamil. Br J Pharmacol 1982; 77: 467
  • 16 Han P, Boatwright C, Ardlie NG. Effect of the calcium entry blocking agent nifedipine on activation of human platelets and comparison with verapamil. Thromb Haemostas 1983; 50: 513-517
  • 17 Han P, Boatwright C, Ardlie NG. Verapamil and collagen-induced platelet reactions. Evidence for a role of intracellular calcium in platelet activation. Thromb Haemostas 1983; 50: 537-540